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Abstract
This study explores the degree to which genetic influences on psychotic experiences are stable across adolescence
and adulthood, and their overlap with psychiatric disorders. Genome-wide association results were obtained for
adolescent psychotic experiences and negative symptom traits (N= 6297–10,098), schizotypy (N= 3967–4057) and
positive psychotic experiences in adulthood (N= 116,787–117,794), schizophrenia (N= 150,064), bipolar disorder
(N= 41,653), and depression (N= 173,005). Linkage disequilibrium score regression was used to estimate genetic
correlations. Implicated genes from functional and gene-based analyses were compared. Mendelian randomization
was performed on trait pairs with significant genetic correlations. Results indicated that subclinical auditory and visual
hallucinations and delusions of persecution during adulthood were significantly genetically correlated with
schizophrenia (rg= 0.27–0.67) and major depression (rg= 0.41–96) after correction for multiple testing. Auditory and
visual subclinical hallucinations were highly genetically correlated (rg= 0.95). Cross-age genetic correlations for
psychotic experiences were not significant. Gene mapping and association analyses revealed 14 possible genes
associated with psychotic experiences that overlapped across age for psychotic experiences or between psychotic
experiences and psychiatric disorders. Mendelian randomization indicated bidirectional associations between auditory
and visual hallucinations in adults but did not support causal relationships between psychotic experiences and
psychiatric disorders. These findings indicate that psychotic experiences in adulthood may be more linked genetically
to schizophrenia and major depression than psychotic experiences in adolescence. Our study implicated specific
genes that are associated with psychotic experiences across development, as well as genes shared between psychotic
experiences and psychiatric disorders.
Introduction
Psychotic experiences (also called “psychotic-like
experiences”) resemble positive symptoms of psychotic
disorders, such as paranoia, hallucinations, and cognitive
symptoms, and have a median prevalence rate of ~7%–8%
in the general population1,2. Negative symptom traits in
the community resemble negative symptoms of psychotic
disorders such as apathy, anhedonia, and social with-
drawal. Schizotypy3 is a related, older personality-based
construct compared with psychotic experiences and
negative symptoms (PENS). Positive psychotic experi-
ences during adolescence or adulthood, especially when
persistent, are associated with an increased risk of devel-
oping psychotic disorders4–9 and, to a lesser extent, with
other psychiatric disorders10–12. Likewise, schizotypy is
associated with subsequently developing psychotic
disorders13.
Twin studies suggest heritability accounts for a third to
a half of variation in PENS during adolescence14–19.
Genome-wide association studies (GWAS) indicate
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modest single-nucleotide polymorphism heritability
(SNP-h2) for some PENS in mid-adolescence (3%–9%)
and for schizotypy in adults (20%–27%)20–22. Psychotic
experiences share genome-wide genetic influences with
schizophrenia and major depression20,23–26, although not
all studies found this, particularly those that used com-
paratively smaller samples or polygenic scores (PGS) from
less well-powered GWAS23,24,27–31. Schizophrenia PGS
has been associated with schizotypy in adults assessed
using semi-structured interviews, but not with self-rated
PENS32. Studies have mainly focussed on adolescents and
young adults rather than older adults and have not
reported on the genetic overlap of psychotic experiences
across age, despite this being an important topic for
understanding the etiology and development of mental
illness. It is also not known whether psychotic experiences
and schizotypy share genetic influences.
This study investigates the genetic overlap between psy-
chotic experiences across age using the largest current
GWAS summary statistics available for adolescent PENS and
for schizotypy and positive psychotic experiences measured
in adulthood. We evaluate genome-wide genetic correlations
and overlapping associated genes between these trait mea-
sures and with schizophrenia, depression, and bipolar dis-
order. For traits and disorders that share common additive
genetic influences, we further explore the nature of these
associations using Mendelian randomization (MR).
Methods and materials
Samples and measures
PENS traits during adolescence
Summary statistics for adolescent PENS came from a
mega-GWAS of three European community samples (N=
6297–10,098)20: Twins Early Developmental Study (TEDS)33,
a community sample born between 1994–1996 in England
and Wales (mean age 16.32 years); Avon Longitudinal Study
of Parents and Children (ALSPAC)34,35, a birth cohort from
the United Kingdom (mean age 16.76 years) born in
1991–1992; and Child and Adolescent Twin Study in Swe-
den (CATSS)36 that recruited twins born in Sweden since
1992 (mean age 18.31 years).
In TEDS, PENS items came from the Specific Psychotic
Experiences Questionnaire37 and were matched by a team
of clinicians to similar items from psychopathology
questionnaires available in CATSS and ALSPAC20. After
harmonization, PENS included four continuous subscales
that assessed the frequency or severity of paranoia and
hallucinations, cognitive disorganization, anhedonia, and
parent-rated negative symptoms.
Schizotypy during adulthood
Schizotypy was assessed in the Northern Finland Birth
Cohort 1996 (NFBC)38 when participants were aged 31
years. GWAS summary statistics22 of four continuous
schizotypy scales were included (N= 3967–4057): per-
ceptual aberrations were assessed with the Perceptual
Aberration Scale39 and included experiences that resem-
ble clinical features of schizophrenia. Hypomania was
from the Hypomanic Personality Scale40, devised to assess
hypomania, gregariousness, grandiosity, and euphoria.
Two scales from Chapman’s Schizotypia Scales were
employed: the Revised Social Anhedonia Scale and the
Revised Physical Anhedonia Scale41, devised to assess the
inability to take pleasure from physical and social stimuli,
respectively.
Positive psychotic experiences assessed in adults
GWAS summary statistics of four dichotomous items
from the UK Biobank were obtained from Neale Lab
(http://www.nealelab.is/uk-biobank) for individuals of
European ancestry (N= 116,787–117,794). Items assessed
psychotic experiences in adults aged 40–69 years: whether
participants ever experienced auditory hallucinations,
visual hallucinations, delusions of persecution, and delu-
sions of reference.
Additional information on psychotic experiences items
are provided in the Supplementary Note.
Psychiatric disorders
GWAS summary statistics for schizophrenia42, bipolar
disorder43, and major depressive disorder44 were down-
loaded from the Psychiatric Genetics Consortium (https://
www.med.unc.edu/pgc/results-and-downloads). Summary
statistics for depression excluded 23andMe participants.
Analyses
Quality-control procedures were applied to summary
statistics prior to analyses. Genetic variants were removed
if they had incomplete association statistics, were non-
biallelic, or strand ambiguous. Variants with alleles that
did not match those in the 1000 Genomes reference panel
(phase 3), with info scores < 0.9 and minor allele fre-
quency < 0.01 were excluded.
Linkage disequilibrium (LD) score regression45 was
used to estimate SNP-h2 for traits and the genetic cor-
relation (rg) between traits. Variants were merged with the
HapMap3 reference panel to ensure good imputation
quality45. Heritability and genetic correlations were con-
verted to liability scales using lifetime prevalence of 1% for
schizophrenia, 15% for depression, and 2% for bipolar
disorder46–48. Effective sample sizes were used for ado-
lescent PENS, because TEDS and CATSS included sib-
lings20. To account for sample overlap, the LD score
regression intercept was left unconstrained to estimate
associations between positive psychotic experiences and
depression, because both included UK Biobank partici-
pants, and between psychiatric disorders that include
PGC participants. Benjamini–Hochberg correction for
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multiple testing was performed at a false discovery rate of
0.05 to account for 105 correlations estimated.
Gene-wide associations and gene mapping were performed
using the FUMA pipeline49 and results were compared
across psychotic experiences and psychiatric disorders. To
identify genes at genome-wide significance, MAGMA v1.0650
was used to aggregate the p-values of SNPs within gene
coding regions (0 kb annotation window). Default parameters
and an SNP-wide mean model were employed. Bonferroni-
corrected p-value thresholds were set for the number of
genes tested within each phenotype. Positional mapping of
variants within 10 kb of gene regions and likely to have
functional consequences (Combined Annotation-Dependent
Depletion score (CADD score) ≥ 12.37), gene mapping using
expression quantitative trait loci associations and chromatin
interactions were performed for independent lead SNPs (at
p < 1 × 10–5 for psychotic experiences, p < 1 × 10−6 for
depression, and p < 1 × 10−8 for schizophrenia and bipolar
disorder) and 1000 Genomes reference panel variants in LD
with independent SNPs at r2 ≥ 0.6 using recommended
parameters49. Additional details are provided in the Supple-
mentary Note.
MR51 was conducted to test for causal relationships
between phenotypes that had significant genetic correlations.
SNPs were selected as instrumental variables based on the
clumping algorithm in PLINK52 using an r2 threshold of 0.05
within a 500 kb window at genome-wide significant levels
(p < 5 × 10−8) for schizophrenia. Summary statistics for
depression did not include 23andMe participants and had an
insufficient number of genome-wide significant variants for
MR analyses. Instead, genome-wide significant variants were
obtained from the publication44. Insufficient genome-wide
significant variants associated with psychotic experiences
meant that p-value thresholds for psychotic experiences were
set at p < 5 × 10−5 to allow for at least 20 instrumental
variables. We report MR analyses using equivalent p-value
thresholds for all phenotypes (p < 5 × 10−5) in the Supple-
mentary Material.
Generalized summary-data-based MR (GSMR) was
used due to its advantages of accounting for residual LD
structure between instrumental variables (set at LD r2 >
0.1) and for sampling variation in the exposure and out-
come GWAS53. MR-Egger regression54, weighted med-
ian55, and weighted mode56 methods were conducted as
sensitivity analyses for possible violation of MR assump-
tions. SNPs identified as potentially pleiotropic or with
residual LD structure in GSMR Heidi-outlier analyses
were also excluded from sensitivity analyses.
Results
Common additive genetic variance accounted for
8%–10% of phenotypic variation in adolescent PENS
(paranoia/hallucinations and negative symptoms did not
have significant SNP-h2 estimates in these analyses),
30%–37% in schizotypy during adulthood, and 7%–10% in
positive psychotic experiences during adulthood (Table 1).
Genetic correlations are shown in Fig. 1. Genetic cor-
relations could not be computed for paranoia and hallu-
cinations, and negative symptoms, likely due to low
SNP-h2. For these comparisons, we report genetic cov-
ariance (ρg), which indicates direction of correlation
(Supplementary Table S1).
Genetic correlations with psychiatric disorders
For positive psychotic experiences in UK Biobank,
auditory hallucinations were significantly genetically cor-
related with schizophrenia (rg= 0.39, p= 2.27 × 10
−5) and
depression (rg= 0.69, p= 8.07 × 10
−6), but not with bipolar
disorder (rg= 0.17, p= 0.082). Likewise, visual hallucina-
tions was significantly correlated with schizophrenia (rg=
0.27, p= 4.12 × 10−7) and depression (rg= 0.41, p= 2.00 ×
10−4) but not with bipolar disorder (rg= 0.14, p= 0.149).
We observed high and significant genetic correlations
between delusions of persecution with schizophrenia (rg=
0.67, p= 0.002) and depression (rg= 0.96, p= 0.001),
whereas the genetic correlation with bipolar disorder was
not significant after correction for multiple testing (rg=
0.65, p= .019). Genetic correlations between delusions of
reference with schizophrenia (rg= 0.72, p= 0.007),
depression (rg= 0.79, p= 0.021) and bipolar disorder (rg=
0.61, p= 0.033) were at nominal significance (p < 0.05) but
did not survive correction for multiple testing.
Between adolescent PENS and psychiatric disorders,
genetic correlations were not significant after correction
for multiple testing. Nominally significant genetic corre-
lations were observed between cognitive disorganization
with schizophrenia (rg= 0.19, p= 0.034) and depression
(rg= 0.40, p= 0.006) and between anhedonia and
depression (rg= 0.33, p= 0.021). Negative symptoms
covaried positively with schizophrenia (ρg= 0.03, p=
1.37 × 10−4) and depression (ρg= 0.03, p= 2.41 × 10
−7).
Positive genetic covariation was observed between para-
noia and hallucinations, and depression (ρg= 0.03, p=
1.43 × 10−4). No significant genetic correlations were
found with bipolar disorder.
Between psychiatric disorders and schizotypy in adults,
hypomania was genetically correlated with depression at
nominal significance (rg= 0.17, p= 0.014). We did not
find evidence that the schizotypy scales correlated with
schizophrenia or bipolar disorder.
Genetic stability of psychotic experiences across age
PENS during adolescence were not significantly
genetically correlated with positive psychotic experiences
and schizotypy during adulthood. Between the adult
samples, hypomania was genetically correlated with visual
hallucinations (rg= 0.37, p= 0.024). Physical anhedonia
showed a negative genetic correlation with auditory
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hallucinations (rg=−0.42, p= 0.034), but not after cor-
rection for multiple testing.
Genetic correlations within samples
Within positive psychotic experiences in UK Biobank,
auditory and visual hallucinations were highly and sig-
nificantly genetically correlated (rg= 0.95, p= 7.61 ×
10−5). Genetic correlations between delusions of refer-
ence with auditory (rg= 0.93, p= 0.038) and visual hal-
lucinations (rg= 0.83, p= 0.050) were not significant after
correction for multiple testing. Delusions of persecution
were not genetically correlated with auditory or visual
hallucinations. A genetic correlation between delusions of
persecution and delusions of reference could not be
computed due to low SNP-h2 in both phenotypes. but
these two items showed positive genetic covariance (ρg=
0.01, p= 0.003).
There was a nominally significant association between
physical and social anhedonia (rg= 0.54, p= 0.044). No
other genetic correlations between schizotypy scales were
significant.
Within adolescent PENS scales, positive genetic covar-
iance was identified between anhedonia and negative
symptoms (ρg= 0.11, p= 0.012). No significant genetic
overlap between other adolescent PENS was found.
Comparison of implicated genes across mapping
strategies and phenotypes
Gene mapping and genome-wide gene association
results from FUMA were compared across psychotic
experiences and psychiatric disorders (Table 2). Full
results for each phenotype are provided in Supple-
mentary Figs. S1–3 and Supplementary Tables S2–7.
Results revealed 32 genes for adolescent PENS, of
which PAN3 mapped to adolescent cognitive dis-
organization and schizotypy in adulthood (perceptual
aberrations), and NADK2 to adolescent negative
symptoms and delusions of reference in UK Biobank;
none overlapped with psychiatric disorders. Seventy-
three genes were found for adult schizotypy including
the aforementioned PAN3 and six genes that were also
indicated for schizophrenia. ANK3 overlapped with
both positive psychotic experiences (visual hallucina-
tions) and schizophrenia. For positive psychotic
experiences in adults, 104 genes were identified, seven
of which overlapped with schizophrenia and, as
Table 1 Genome-wide association study sample sizes and SNP-heritability estimates.
GWAS N N cases QC-positive SNPs SNP-h2 SE p
Adolescent psychotic experiences and negative symptom traits
Paranoia and hallucinations 8665 Continuous 3,363,829 −0.0042 0.0352 0.453
Cognitive disorganization 6297 Continuous 3,363,829 0.1048 0.0566 0.032
Anhedonia 6579 Continuous 3,363,829 0.0797 0.0479 0.048
Parent-rated negative symptoms 10,098 Continuous 3,363,829 −0.0222 0.0316 0.241
Schizotypy during adulthood
Hypomania 3967 Continuous 5,493,986 0.3732 0.1011 <0.001
Perceptual aberrations 4057 Continuous 5,493,986 0.3037 0.0916 <0.001
Physical anhedonia 3988 Continuous 5,493,986 0.3655 0.0965 <0.001
Social anhedonia 4025 Continuous 5,493,986 0.2950 0.0826 <0.001
Positive psychotic experiences during adulthood
Auditory hallucinations 117,503 2009 6,443,634 0.0709 0.0255 0.003
Visual hallucinations 116,787 3768 6,443,706 0.1032 0.0224 <0.001
Delusions of persecution 117,794 932 6,443,695 0.0910 0.0521 0.040
Delusions of reference 117,731 822 6,443,693 0.0666 0.0499 0.091
Psychiatric disorders
Schizophrenia 150,064 36,989 5,274,747 0.1631 0.0044 <0.001
Bipolar disorder 41,653 20,129 5,083,505 0.2999 0.0102 <0.001
Major Depression 173,005 59,851 5,488,968 0.0999 0.0042 <0.001
SNP-h2 univariate SNP heritability. SNP-h2 converted to a liability scale for binary traits; effective sample size used for adolescent PENS in LD score regression analyses
to account for the presence of siblings (paranoia and hallucinations= 7970.416; cognitive disorganization= 5082.760; anhedonia= 6068.311; parent-rated negative
symptoms= 8763.295).
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mentioned above, one with schizotypy and one with
adolescent PENS (Fig. 2).
Mendelian randomization
Results from GSMR analyses and MR sensitivity ana-
lyses are summarized in Table 3, and MR-Egger intercept
tests, heterogeneity statistics, and plots in Supplementary
Table S8 and Supplementary Figs. S4–5.
GSMR analyses provided evidence for a bidirectional
association between auditory and visual hallucinations
(PGSMR= 1.73 × 10
−21 for auditory hallucinations as the
exposure; PGSMR= 4.25 × 10
−25 for visual hallucinations as
the exposure) and replicated in all MR sensitivity analyses.
We observed evidence of a directional effect of schizo-
phrenia liability on delusions of persecution (PGSMR=
9.33 × 10−5); however, the effect was small and replicated
in weighted median but not in MR-Egger, nor in weighted
mode analyses. No evidence of a significant effect in the
other direction was found.
Only the MR-Egger method indicated significant direc-
tional effects of a liability to depression on a propensity to
report auditory hallucinations and delusions of persecution.
However, MR-Egger intercept tests indicated the presence of
directional pleiotropy in both instances (Supplementary
Table S8), indicating that MR-Egger results may be reliable
as it adjusts for non-zero intercepts allowing for more robust
estimates when horizontal pleiotropy is present compared
with the other methods. The discrepancy between MR
methods may also be due to outliers not identified by Heidi-
outlier analysis. MR analyses using IVs selected at p < 5 ×
10−5 for all exposures did not affect our main conclusions
(Supplementary Table S9).
Discussion
This study investigated whether common genetic
variation underlying psychotic experiences overlaps
across adolescence and adulthood, and with psychiatric
disorders. Our results suggest that with increasing age
Fig. 1 Heat map showing genetic correlations between psychotic experiences and psychiatric disorders. PENS, Psychotic experiences (PE)
and negative symptom traits; NA, genetic correlations could not be computed due to low SNP heritability or sample size (see Supplementary Table
S1 for genetic covariance estimates). *Nominally statistically significant genetic correlations at p < .05; **genetic correlations that survived
Benjamini–Hochberg correction for multiple testing for 105 pairwise correlations (at a FDR of 0.05); genetic correlations reported using unconstrained
LD score regression intercept between phenotypes with sample overlap.
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from adolescence to adulthood, psychotic experiences
become more linked genetically to schizophrenia and
major depression. We did not observe evidence of sig-
nificant genetic stability of psychotic experiences across
adolescence and adulthood in existing data. However,
our study implicated specific genes that are associated
with psychotic experiences across development and
genes shared between psychotic experiences and psy-
chiatric disorders.
Associations between psychotic experiences and
psychiatric disorders
We found that positive psychotic experiences in UK Bio-
bank (specifically experiences of auditory and visual halluci-
nations) shared a moderate to substantial amount of
common genetic variation with depression and schizo-
phrenia, consistent with an independent report26. Our MR
analyses indicated that liability to schizophrenia may be
directionally associated with a propensity to experience
delusions of persecution and depression liability with a pro-
pensity to report auditory hallucinations and delusions of
persecution. This latter finding concurs with a twin study
showing that depression and psychotic experiences pheno-
typically influence one another in adolescence over and
above genetic influences57. However, these MR effect sizes
were small and not consistently replicated in sensitivity
analyses, and are therefore unlikely to reflect true causal
effects.
This study reported genetic overlap between adolescent
PENS and psychiatric disorders. We used more recent
summary statistics from larger GWAS of depression and
bipolar disorder43,44, which allowed more reliable esti-
mations compared with previous studies20. Our results
add to the growing body of evidence that there are genetic
associations between adolescent PENS and psychiatric
disorders20,24. There were more significant genetic cor-
relations between psychotic experiences and depression
than with schizophrenia. This could be explored further
in terms of the underlying reasons.
Schizotypy domains did not appear to share common
additive genetic influences with schizophrenia nor with
bipolar disorder. There was suggestive evidence of genetic
overlap between hypomania and depression. Schizotypy
has been associated with an increased risk of
schizophrenia-spectrum disorders13, but longitudinal
evidence of an association between schizotypy and sub-
sequently being diagnosed with schizophrenia is limited58
and findings inconsistent59.
Bipolar disorder does not appear to share genetic
overlap with adolescent PENS or adult schizotypy. It is
possible that common genetic influences on bipolar dis-
order, in contrast to those on depression and schizo-
phrenia, are not involved in these earlier adolescent forms
of psychopathology. Future studies with better-powered
GWAS will be able to test this hypothesis further.
We found evidence that some genes may be involved in
both psychotic experiences and psychiatric disorders.
Seven genes were implicated in both positive psychotic
experiences in UK Biobank and schizophrenia: ANK3, a
gene in the 10q21.2 region, has previously been associated
with bipolar disorder and schizophrenia60–62. TSNARE1
(8q24.3) has previously been implicated in schizophrenia
and cognitive function42,63. The gene SNX7 (1p21.3) has
known associations with mathematical ability64. Three
neighboring genes located on band 12q24.11, FAM216A,
PPP1CC, and GPN3, and a nearby gene TMEM116
(12q24.13) have been associated with white blood cell and
platelet count, heart rate, and body mass index65–67.
Six mapped genes overlapped between adult schizotypy
and psychiatric disorders, including ANK3 discussed
above. As noted elsewhere22, we found evidence that
CACNA1C (12p13.33), with well-replicated associations
with psychiatric and developmental disorders42,60,61, may
be involved in hypomania, schizophrenia, and bipolar
Adolescent 
PENS
Schizotypy in 
adults
Positive PE in 
adults
Psychiatric 
disorders
ANK3
NADK2
96 genes
0 
FAM216A
TMEM116
TSNARE1 
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30 genes 545 genes
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Fig. 2 Number of overlapping genes between psychotic experiences across age and psychiatric disorders. PENS, Psychotic experiences (PE)
and negative symptom traits. Genes identified using (a) genome-wide gene associations in MAGMA after Bonferroni correction for the number of
gene associations tested, (b) positional mapping that prioritized genes based on variant functional annotations obtained using ANNOVAR, (c) eQTL
(expressive quantitative trait) mapping, and (d) chromatin interaction mapping.
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disorder. Located within the same 12p13.33 region, the
genes DCP1B, TSPAN9, and FKBP4 also overlapped
between hypomania and schizophrenia, and have pre-
viously been associated with a range of physical health
phenotypes including obesity and waist–hip ratio66,68.
Findings indicated the possible involvement of CLK1
(2q33.1) in perceptual aberrations and schizophrenia, a
gene previously associated with breast cancer69.
Our results suggest that psychotic experiences may
share more genome-wide genetic overlap with schizo-
phrenia and major depression in adulthood than adoles-
cence. Participants had narrow age ranges in the
adolescent PENS (15–19 years old) and adult schizotypy
(all born in the same year) samples, and were assessed on
current psychotic experiences, whereas UK Biobank par-
ticipants had a wider and older age range (40–69 years
old), and were asked to report on lifetime psychotic
experiences. It is therefore possible that psychotic
experiences reported in UK Biobank may have been
persistent rather than transitory. According to the
persistent-impairment model, those with persistent psy-
chotic experiences are at a higher risk of developing
psychotic disorders and may therefore share more genetic
influences with psychiatric disorders70. It is also possible
that some of those in the adolescent samples may be
genetically liable to psychotic experiences but will have
not yet developed them. A previous study found that
genetic liability to schizophrenia was positively associated
with adolescent paranoia and hallucinations only after
excluding non-zero scores20, suggesting that genetic lia-
bility to schizophrenia may vary in adolescents who did
not (yet) report psychotic experiences. This may explain
why we found that genetic overlap between psychotic
experiences and psychiatric disorders increased with age.
Stability of genetic influences on psychotic experiences
across age
We did not find significant genetic overlap across PENS
(adolescence), schizotypy (adulthood), and positive psy-
chotic experiences (adulthood). Different genetic influ-
ences may be involved in psychotic experiences across the
lifespan. For example, some psychotic experiences may be
adolescent-specific, tied in with development and lifestyle
factors such as sleep problems, risk-taking, and experi-
menting with drugs. Psychotic experiences in older adults
may have different etiological pathways, in part associated
with conditions such as medication side effects, dementia,
eye conditions, and Charles Bonnet syndrome. However,
it was not possible to rule out that the different mea-
surements used across ages led to the lack of genetic
overlap. Another reason why no cross-age genetic overlap
was found may be the smaller GWAS sample sizes for
adolescent PENS and adult schizotypy. In agreement with
our findings, an independent report found that genetic
risk for psychotic experiences in adults did not predict
psychotic experiences during mid-adolescence26.
We found that some of the same genes may be involved in
psychotic experiences across age. The gene ANK3 was
implicated for adult schizotypy and adult psychotic experi-
ences. The gene PAN3 (13q12.2) was implicated in adoles-
cent cognitive disorganization and schizotypy. NADK2
(mitochondrial) on 5p13.2 was mapped to both negative
symptoms in adolescence and to adult psychotic experiences.
Within-sample associations between specific types of
psychotic experiences
We also investigated within-sample genetic associations
and found that auditory and visual hallucinations during
adulthood shared the same common genetic influences
and were bidirectionally associated in MR analyses. This
bidirectional association may indicate a pervasive shared
genetic basis between auditory and visual hallucinatory
experiences rather than true causal associations, because
pleiotropic effects of the genetic instruments through a
latent common precursor (which would violate MR
assumptions) seem likely. As such, experiences resem-
bling auditory and visual hallucinations may share biolo-
gical pathways.
Limitations
We note caution in interpreting MR results that com-
pared within-sample psychotic experiences, because
sample overlap could lead to weak instrument bias away
from the null71. We may not have detected true causal
effects due to weak instrument bias in analyses that used
psychotic experiences as the exposure, because genetic
variants below conventional genome-wide significance
levels were used. Future studies could re-evaluate these
causal associations once larger GWAS for psychotic
experiences become available. Furthermore, future studies
with greater power might explore the associations of
psychotic experiences with a wider array of phenotypes.
Many of the overlapping genes we report were identified
based mainly on chromatin interactions. The chromatin
interaction data had a high resolution (10 kb) resulting in
more mapped genes and included enhancer–promoter
and promoter–promoter interactions only72, therefore
providing strong hypotheses for variant–gene associa-
tions. For psychotic experiences and depression, func-
tional consequences on genes were annotated to variants
clumped below conventional genome-wide significance
levels. As such, these results will benefit from replication
once better-powered GWAS become available.
There are known limitations when using summary
statistics from large biobanks including ascertainment
bias and the possibility that collider bias may result in
overinflated genetic correlations73,74. Loss to follow-up in
the cohort studies used in GWAS may have an impact on
Barkhuizen et al. Translational Psychiatry           (2020) 10:86 Page 10 of 12
the generalizability of the genetic findings75. However, we
note that attrition based on phenotypic or genetic risk for
psychosis would lead, if anything, to underestimates of the
genetic overlap between psychotic experience traits and
psychiatric disorders.
Implications and conclusions
Psychotic experiences during adulthood and adolescence
share genetic influences with psychiatric disorders. This
study implicated specific genes that may be involved in both
psychotic experiences in the community and psychiatric
disorders, and genes associated with psychotic experiences
across development. Subclinical experiences of auditory and
visual hallucinations in adults may have similar biological
etiologies. Our findings and other independent reports
indicate that psychotic experiences assessed using different
measures at different developmental stages may not reflect
genetically similar phenomena.
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